Boehringer Ingelheim Zantac Cancer Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
Boehringer Ingelheim · Zantac (ranitidine) · Ongoing Litigation
Last updated
Case overview
- Defendant company
- Boehringer Ingelheim
- Product or service
- Zantac (ranitidine)
- Case status
- Ongoing Litigation
- Lawsuit type
- Consumer
- Reported harm
- Product Defect
Participation information
Availability is based on each listed participation option and its deadline.
No active participation options are currently listed.
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.